Edward T Moseley

Safety and immunogenicity of a Zika purified inactivated virus vaccine given via standard, accelerated, or shortened schedules: a single-centre, double-blind, sequential-group, randomised, placebo-controlled, phase 1 trial.

Stephen J. Thomas, N. Michael, D. Barouch, 2020, The Lancet. Infectious diseases.

Sustained maternal antibody and cellular immune responses in pregnant women infected with Zika virus and mother to infant transfer of Zika‐specific antibodies

D. Barouch, Lauren Peter, E. Borducchi, 2020, American journal of reproductive immunology.

Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys

Jessica Jimenez, Galit Alter, Kayvon Modjarrad, 2016, Science.

Vaccine Protection Against Zika Virus from Brazil

Richard G. Jarman, Zhenfeng Li, Nelson L. Michael, 2016, Nature.